Literature DB >> 22615315

In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genes.

Carolina Bustamante1, Onikepe A Folarin, Grace O Gbotosho, Camila N Batista, Elieth A Mesquita, Rodrigo M Brindeiro, Amilcar Tanuri, Claudio J Struchiner, Akintunde Sowunmi, Ayoade Oduola, Dyann F Wirth, Mariano G Zalis, Christian T Happi.   

Abstract

Plasmodium falciparum with reduced sensitivity to artemisinin derivatives has been observed in endemic areas, but the molecular mechanisms for this reduced sensitivity remain unclear. We evaluated the association between in vitro susceptibility of P. falciparum isolates obtained from southwest Nigeria and polymorphisms in selected putative transporter genes (PFE0775C, PF13_0271, pfmrp1, pfcrt, and pfmdr1). Modified schizont inhibition assay was used to determine the in vitro parasite susceptibility to artemether (ATH). Polymorphisms in selected genes were detected by polymerase chain reaction followed by direct DNA sequencing. The half-maximal inhibitory concentration (IC(50)) geometric mean (GM) for all P. falciparum isolates was 1.78 nM (range, 0.03-10.43 nM). Polymorphisms at codons 241, 86, and 76 of PFE0775C, pfmdr1, and pfcrt genes, respectively, were associated with reduced susceptibility to ATH. A new S263P single-nucleotide polymorphism on the PFE0775C gene was also detected in 27% of the isolates. Patient isolates harboring V241L or S263P polymorphisms on the PFE0775C gene showed increased IC(50) (GM: 3.08 nM and 1.79 nM, respectively). Plasmodium falciparum isolates harboring mutant Y86 pfmdr1 and P263 PFE0775C alleles showed a 2.5-5.5-fold increase in ATH IC(50.) This study shows that polymorphisms on the PFE0775C and pfmdr1 genes are associated with reduced sensitivity to ATH in fresh isolates of P. falciparum from Nigeria.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22615315      PMCID: PMC3490696          DOI: 10.1093/infdis/jis359

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  46 in total

1.  Averting a malaria disaster.

Authors:  N J White; F Nosten; S Looareesuwan; W M Watkins; K Marsh; R W Snow; G Kokwaro; J Ouma; T T Hien; M E Molyneux; T E Taylor; C I Newbold; T K Ruebush; M Danis; B M Greenwood; R M Anderson; P Olliaro
Journal:  Lancet       Date:  1999-06-05       Impact factor: 79.321

Review 2.  Transporters involved in resistance to antimalarial drugs.

Authors:  Stephanie G Valderramos; David A Fidock
Journal:  Trends Pharmacol Sci       Date:  2006-09-25       Impact factor: 14.819

3.  Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6.

Authors:  Ronan Jambou; Eric Legrand; Makhtar Niang; Nimol Khim; Pharath Lim; Béatrice Volney; Marie Thérèse Ekala; Christiane Bouchier; Philippe Esterre; Thierry Fandeur; Odile Mercereau-Puijalon
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

4.  Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.

Authors:  C T Happi; G O Gbotosho; O A Folarin; O M Bolaji; A Sowunmi; D E Kyle; W Milhous; D F Wirth; A M J Oduola
Journal:  Am J Trop Med Hyg       Date:  2006-07       Impact factor: 2.345

5.  Phenotypic and genotypic analysis of in vitro-selected artemisinin-resistant progeny of Plasmodium falciparum.

Authors:  Matthew S Tucker; Tina Mutka; Kansas Sparks; Janus Patel; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

6.  In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.

Authors:  Saowanit Vijaykadga; Chaiporn Rojanawatsirivej; Sawat Cholpol; Duangduen Phoungmanee; Argat Nakavej; Chansuda Wongsrichanalai
Journal:  Trop Med Int Health       Date:  2006-02       Impact factor: 2.622

7.  Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria.

Authors:  Nancy O Duah; Michael D Wilson; Anita Ghansah; Ben Abuaku; Dominic Edoh; Neils B Quashie; Kwadwo A Koram
Journal:  J Trop Pediatr       Date:  2006-12-10       Impact factor: 1.165

8.  Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.

Authors:  Amar Bir Singh Sidhu; Anne-Catrin Uhlemann; Stephanie G Valderramos; Juan-Carlos Valderramos; Sanjeev Krishna; David A Fidock
Journal:  J Infect Dis       Date:  2006-07-11       Impact factor: 5.226

9.  Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10.

Authors:  A Afonso; P Hunt; S Cheesman; A C Alves; C V Cunha; V do Rosário; P Cravo
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

10.  Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.

Authors:  Sandrine Cojean; Alain Noël; Dimitri Garnier; Véronique Hubert; Jacques Le Bras; Rémy Durand
Journal:  Malar J       Date:  2006-03-28       Impact factor: 2.979

View more
  14 in total

1.  Altered temporal response of malaria parasites determines differential sensitivity to artemisinin.

Authors:  Nectarios Klonis; Stanley C Xie; James M McCaw; Maria P Crespo-Ortiz; Sophie G Zaloumis; Julie A Simpson; Leann Tilley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

2.  Artemether Exhibits Amoebicidal Activity against Acanthamoeba castellanii through Inhibition of the Serine Biosynthesis Pathway.

Authors:  Yihong Deng; Wei Ran; Suqin Man; Xueping Li; Hongjian Gao; Wei Tang; Hiroshi Tachibana; Xunjia Cheng
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

3.  Structure-based approach to the identification of a novel group of selective glucosamine analogue inhibitors of Trypanosoma cruzi glucokinase.

Authors:  Edward L D'Antonio; Mason S Deinema; Sean P Kearns; Tyler A Frey; Scott Tanghe; Kay Perry; Timothy A Roy; Hanna S Gracz; Ana Rodriguez; Jennifer D'Antonio
Journal:  Mol Biochem Parasitol       Date:  2016-01-14       Impact factor: 1.759

4.  Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.

Authors:  Nancy O Duah; Sena A Matrevi; Dziedzom K de Souza; Daniel D Binnah; Mary M Tamakloe; Vera S Opoku; Christiana O Onwona; Charles A Narh; Neils B Quashie; Benjamin Abuaku; Christopher Duplessis; Karl C Kronmann; Kwadwo A Koram
Journal:  Malar J       Date:  2013-10-30       Impact factor: 2.979

5.  Analysis of polymorphisms in Plasmodium falciparum genes related to drug resistance: a survey over four decades under different treatment policies in Brazil.

Authors:  Juliana Inoue; Dinora Lopes; Virgílio do Rosário; Marta Machado; Angélica D Hristov; Giselle Fmc Lima; Maria J Costa-Nascimento; Aluísio C Segurado; Silvia M Di Santi
Journal:  Malar J       Date:  2014-09-19       Impact factor: 2.979

6.  Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial.

Authors:  Peter G Kremsner; Akim A Adegnika; Aurore B Hounkpatin; Jeannot F Zinsou; Terrie E Taylor; Yamikani Chimalizeni; Alice Liomba; Maryvonne Kombila; Marielle K Bouyou-Akotet; Denise P Mawili Mboumba; Tsiri Agbenyega; Daniel Ansong; Justice Sylverken; Bernhards R Ogutu; Godfrey A Otieno; Anne Wangwe; Kalifa A Bojang; Uduak Okomo; Frank Sanya-Isijola; Charles R Newton; Patricia Njuguna; Michael Kazungu; Reinhold Kerb; Mirjam Geditz; Matthias Schwab; Thirumalaisamy P Velavan; Christian Nguetse; Carsten Köhler; Saadou Issifou; Stefanie Bolte; Thomas Engleitner; Benjamin Mordmüller; Sanjeev Krishna
Journal:  PLoS Med       Date:  2016-01-12       Impact factor: 11.069

Review 7.  Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature.

Authors:  Gabriel Luíz Costa; Lara Cotta Amaral; Cor Jesus Fernandes Fontes; Luzia Helena Carvalho; Cristiana Ferreira Alves de Brito; Taís Nóbrega de Sousa
Journal:  Malar J       Date:  2017-04-19       Impact factor: 2.979

8.  Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children.

Authors:  Stephen Oguche; Henrietta U Okafor; Ismaila Watila; Martin Meremikwu; Philip Agomo; William Ogala; Chimere Agomo; Godwin Ntadom; Olajide Banjo; Titilope Okuboyejo; Gboye Ogunrinde; Friday Odey; Olugbemiga Aina; Tolulope Sofola; Akintunde Sowunmi
Journal:  Am J Trop Med Hyg       Date:  2014-09-22       Impact factor: 2.345

9.  Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria.

Authors:  Akintunde Sowunmi; Kazeem Akano; Adejumoke I Ayede; Elsie O Adewoye; Godwin Ntadom; Bayo Fatunmbi; Grace O Gbotosho; Onikepe A Folarin; Christian T Happi
Journal:  BMC Infect Dis       Date:  2017-01-31       Impact factor: 3.090

10.  Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria.

Authors:  Akintunde Sowunmi; Godwin Ntadom; Kazeem Akano; Folasade O Ibironke; Adejumoke I Ayede; Chimere Agomo; Onikepe A Folarin; Grace O Gbotosho; Christian Happi; Stephen Oguche; Henrietta U Okafor; Martin Meremikwu; Philip Agomo; William Ogala; Ismaila Watila; Olugbenga Mokuolu; Finomo Finomo; Joy C Ebenebe; Nma Jiya; Jose Ambe; Robinson Wammanda; George Emechebe; Wellington Oyibo; Francis Useh; Temitope Aderoyeje; Titilope M Dokunmu; Omobolaji T Alebiosu; Sikiru Amoo; Oluwabunmi K Basorun; Olubunmi A Wewe; Chukwuebuka Okafor; Odafe Akpoborie; Bayo Fatunmbi; Elsie O Adewoye; Nnenna M Ezeigwe; Ayoade Oduola
Journal:  Infect Dis Poverty       Date:  2019-08-06       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.